Mizuho reiterated its bullish stance on biotech Neumora Therapeutics Inc. on Wednesday, and predicted a positive outcome when ...

Bipolar disorder is a long-term mood disorder characterized by major fluctuations in mood — both high and low — that can impact daily functioning and behavior. Although bipolar disorder is a ...

Addition of the antipsychotic lumateperone (Caplyta) to an existing antidepressant improved symptoms of depression in a ...

“How Can I Forgive My Cheating Partner?” is out now! Annie Lane’s second anthology — featuring favorite columns on marriage, ...

Bipolar disorder therapies include dialectical behavior therapy, cognitive behavioral therapy, family-focused therapy, and interpersonal and social rhythm therapy. These therapies may help people ...

Sep. 19, 2024 — Researchers report significant strides in enhancing early diagnosis of bipolar disorder in adolescents. They demonstrate the efficacy of integrating multimodal MRI with ...

Neurocrine Biosciences, Inc.'s potential for growth in the biopharma sector is strong despite recent setbacks, making its ...

We provide investigator training in psychiatric rating scales and standardized diagnostic instruments ... Safety and Tolerability of Cariprazine in Patients with Bipolar I Depression" Principal ...

Presentations include results from two pivotal studies (Studies 501 and 502) evaluating lumateperone as an adjunctive therapy to antidepressants ...

Bipolar disorder. Screen for risk factors ... Score from baseline to endpoint in investigator ratings on the ADHD Rating Scale (ADHD-RS). All doses of Vyvanse were found to be superior to placebo ...

The primary outcomes were the remission of symptoms and response to treatment, assessed using scales such as the Hamilton Rating Scale ... depressive disorder, nor bipolar or unipolar subtypes ...

Neumora Therapeutics, Inc. (NMRA – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst ...